In the ultra-non-invasive age, Carrier Screening is to lead the high-level prevention and control of birth defects.
Realize simultaneous detection of 20 high-incidence genetic diseases at one time
The combined use of multiple technology platforms covers multiple forms of mutations, and the detection rate of population carrying exceeds 20%
The test can be completed and verified within 15 natural days/ calendar days
The detection targeting only pathogenic mutations assists clinical interpretation
There is a comprehensive insurance plan for false negatives
Preimplantation genetic testing for Monogenic Disease (PGT-M) can effectively block the genetic changes that may be causing or contributing to a disease and provide an overall solution
1 couples suffering stillbirth or miscarriage for unknown reason
2 Couples with abnormal chromosomes
3 Couples with abnormal reproductive history
4 Couples who have a child inheriting a monogenetic disease or have familial genetic diseases
5 Sperm/egg donors
6 Women who are concerned about recessive inherited diseases during pregnancy (gestational week <16)